Furthermore, we found that the ratios of pro-/anti-inflammatory cytokines are significantly lower in AML with highly expressing ITGAM and lncRNA ITGB2-AS1 than in those lowly expressing ITGAM and lncRNA ITGB2-AS1. This evidence concerns the gene ITGAM and acute myeloid leukemia.